Form 144 Filer Information UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 144

NOTICE OF PROPOSED SALE OF SECURITIES
PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

Form 144

144: Issuer Information

Name of Issuer
Jounce Therapeutics, Inc.
SEC File Number
001-37998
Address of Issuer
780 MEMORIAL DRIVE
CAMBRIDGE
MASSACHUSETTS
02139
Phone
857-259-3840
Name of Person for Whose Account the Securities are To Be Sold
Drapkin Kimberlee C
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer
  1. Officer

144: Securities Information


RecordTitle of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
#1Common Stock
ETrade Financial Corporation
3 Edison Drive
Alpharetta
GEORGIA
30005
15,000$17,100.0051,694,23701/09/2023
Nasdaq Stock Market

144: Securities To Be Sold

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

RecordTitle of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
#1Common Stock01/06/2023Vesting of restricted stock unitsIssuer☐ — 25,48301/06/2023(1)


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

144: Securities Sold During The Past 3 Months

Nothing to Report☒

144: Remarks and Signature

Remarks
(1) The securities to be sold were received upon the settlement of vested restricted stock units. Under the applicable plan and award agreement, upon vesting, restricted stock units are settled in shares of Common Stock on a 1-for-1 basis without any payment.
Date of Notice
01/06/2023
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1
  1. 08/16/2018

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature
/s/ Caroline Gammill, attorney-in-fact

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Documents

File Name:
DrapkinPOA2023.txt
Conformed Form Type:
EX-24
Related Form Type:
Description:
Drapkin Power of Attorney
Contents:
TElNSVRFRCBQT1dFUiBPRiBBVFRPUk5FWSBGT1IgU0VDVElPTiAxNiBSRVBPUlRJTkcgT0JM SUdBVElPTlMNCktub3cgYWxsIGJ5IHRoZXNlIHByZXNlbnQsIHRoYXQgdGhlIHVuZGVyc2ln bmVkIGhlcmVieSBtYWtlcywgDQpjb25zdGl0dXRlcyBhbmQgYXBwb2ludHMgZWFjaCBvZiBK YWNxdWVseW4gRmFoZXkgDQpTYW5kZWxsLCBFbGl6YWJldGggU2hvcnRzbGVldmUgYW5kIENh cm9saW5lIEdhbW1pbGwsIHNpZ25pbmcgc2luZ2x5IA0KYW5kIGVhY2ggYWN0aW5nIGluZGl2 aWR1YWxseSwgYXMgdGhlIHVuZGVyc2lnbmVkIHMgdHJ1ZSBhbmQgbGF3ZnVsIA0KYXR0b3Ju ZXkgaW4gZmFjdCB3aXRoIGZ1bGwgcG93ZXIgYW5kIGF1dGhvcml0eSBhcyBoZXJlaW5hZnRl ciBkZXNjcmliZWQNCnRvOg0KKGkpIGV4ZWN1dGUgZm9yIGFuZCBvbiBiZWhhbGYgb2YgdGhl IHVuZGVyc2lnbmVkLCBpbiB0aGUgdW5kZXJzaWduZWQncw0KIGNhcGFjaXR5IGFzIGEgZGly ZWN0b3IsIG9mZmljZXIgYW5kIG9yIHN0b2NraG9sZGVyICBvZiANCkpvdW5jZSBUaGVyYXBl dXRpY3MsIEluYy4gKHRoZSBDb21wYW55KSwgRm9ybXMgMywgNCwgYW5kIDUNCihpbmNsdWRp bmcgYW55IGFtZW5kbWVudHMgdGhlcmV0bykgaW4gYWNjb3JkYW5jZSB3aXRoIA0KU2VjdGlv biAxNihhKSBvZiB0aGUgU2VjdXJpdGllcyBFeGNoYW5nZSBBY3Qgb2YgMTkzNCBhbmQgdGhl IHJ1bGVzIHRoZXJldW5kZXINCiAodGhlIEV4Y2hhbmdlIEFjdCkgYW5kL29yIEZvcm1zIDE0 NCAoaW5jbHVkaW5nIGFueSBhbWVuZG1lbnRzIHRoZXJldG8pDQogaW4gYWNjb3JkYW5jZSB3 aXRoIFJ1bGUgMTQ0IChSdWxlIDE0NCkNCiB1bmRlciB0aGUgU2VjdXJpdGllcyBBY3Qgb2Yg MTkzMywgYXMgYW1lbmRlZCAodGhlIFNlY3VyaXRpZXMgQWN0KTsNCihpaSkgZG8gYW5kIHBl cmZvcm0gYW55IGFuZCBhbGwgYWN0cyBmb3IgYW5kIG9uIGJlaGFsZiBvZiB0aGUgdW5kZXJz aWduZWQgDQp3aGljaCBtYXkgYmUgbmVjZXNzYXJ5IG9yIGRlc2lyYWJsZSB0byBwcmVwYXJl LCBjb21wbGV0ZSANCmFuZCBleGVjdXRlIGFueSBzdWNoIEZvcm0gMywgNCwgb3IgNSBvciBG b3JtIDE0NCwgcHJlcGFyZSwgY29tcGxldGUgYW5kIGV4ZWN1dGUNCiBhbnkgYW1lbmRtZW50 IG9yIGFtZW5kbWVudHMgdGhlcmV0bywgYW5kIHRpbWVseSBkZWxpdmVyIGFuZCBmaWxlIHN1 Y2ggZm9ybSANCndpdGggdGhlIFVuaXRlZCBTdGF0ZXMgU2VjdXJpdGllcyBhbmQgRXhjaGFu Z2UgQ29tbWlzc2lvbiAodGhlIFNFQykgYW5kIA0KYW55IHN0b2NrIGV4Y2hhbmdlIG9yIHNp bWlsYXIgIGF1dGhvcml0eSwgaW5jbHVkaW5nIHdpdGhvdXQgbGltaXRhdGlvbiB0aGUgDQpl eGVjdXRpb24gYW5kIGZpbGluZyBvZiBhIEZvcm0gSUQgb3IgYW55IG90aGVyIGFwcGxpY2F0 aW9uIG1hdGVyaWFscyANCnRvIGVuYWJsZSB0aGUgdW5kZXJzaWduZWQgdG8gZ2FpbiBvciBt YWludGFpbiBhY2Nlc3MgdG8gDQp0aGUgRWxlY3Ryb25pYyBEYXRhIEdhdGhlcmluZywgQW5h bHlzaXMgYW5kIFJldHJpZXZhbCBzeXN0ZW0NCiBvZiB0aGUgU0VDOw0KKGlpaSkgc2VlayBv ciBvYnRhaW4sIGFzIHRoZSB1bmRlcnNpZ25lZCdzIHJlcHJlc2VudGF0aXZlIGFuZCBvbiAN CnRoZSB1bmRlcnNpZ25lZCdzIGJlaGFsZiwgaW5mb3JtYXRpb24gcmVnYXJkaW5nIHRyYW5z YWN0aW9ucyBpbiANCnRoZSBDb21wYW55J3Mgc2VjdXJpdGllcyBmcm9tIGFueSB0aGlyZCBw YXJ0eSwgaW5jbHVkaW5nIA0KYnJva2VycywgZW1wbG95ZWUgYmVuZWZpdCBwbGFuIGFkbWlu aXN0cmF0b3JzIGFuZCB0cnVzdGVlcywgYW5kIHRoZSANCnVuZGVyc2lnbmVkIGhlcmVieSBh dXRob3JpemVzIGFueSBzdWNoIHRoaXJkIHBhcnR5IHRvIHJlbGVhc2UNCmFueSBzdWNoIGlu Zm9ybWF0aW9uIHRvIHRoZSBoZXJlaW4gYXBwb2ludGVkIGF0dG9ybmV5IGluIGZhY3QgYW5k DQphcHByb3ZlcyBhbmQgcmF0aWZpZXMgYW55IHN1Y2ggcmVsZWFzZSBvZiBpbmZvcm1hdGlv bjsgYW5kDQooaXYpIHRha2UgYW55IG90aGVyIGFjdGlvbiBvZiBhbnkgdHlwZSB3aGF0c29l dmVyIGluIGNvbm5lY3Rpb24gDQp3aXRoIHRoZSBmb3JlZ29pbmcgIHdoaWNoLCBpbiB0aGUg b3BpbmlvbiBvZiBzdWNoIA0KYXR0b3JuZXkgaW4gZmFjdCwgbWF5IGJlIG9mIGJlbmVmaXQg dG8sIGluIHRoZSBiZXN0IGludGVyZXN0IA0Kb2YsIG9yIGxlZ2FsbHkgcmVxdWlyZWQgYnks IHRoZSB1bmRlcnNpZ25lZCwgIGl0IGJlaW5nIHVuZGVyc3Rvb2QgDQp0aGF0IHRoZSBkb2N1 bWVudHMgZXhlY3V0ZWQgYnkgc3VjaCBhdHRvcm5leSBpbiBmYWN0IG9uIGJlaGFsZiBvZiAN CnRoZSB1bmRlcnNpZ25lZCBwdXJzdWFudCB0byB0aGlzIFBvd2VyIG9mIEF0dG9ybmV5IHNo YWxsIGJlIGluIA0Kc3VjaCBmb3JtIGFuZCBzaGFsbCBjb250YWluIHN1Y2ggdGVybXMgYW5k IGNvbmRpdGlvbnMgYXMgDQpzdWNoIGF0dG9ybmV5IGluIGZhY3QgbWF5IGFwcHJvdmUgaW4g c3VjaCBhdHRvcm5leSBpbiBmYWN0J3MgZGlzY3JldGlvbi4NCg0KVGhlIHVuZGVyc2lnbmVk IGhlcmVieSBncmFudHMgdG8gZWFjaCBzdWNoIGF0dG9ybmV5IGluIGZhY3QgZnVsbCBwb3dl ciANCmFuZCBhdXRob3JpdHkgdG8gZG8gYW5kIHBlcmZvcm0gYW55IGFuZCBldmVyeSBhY3Qg YW5kIHRoaW5nIHdoYXRzb2V2ZXIgIA0KcmVxdWlzaXRlLCBuZWNlc3NhcnksIG9yIHByb3Bl ciB0byBiZSBkb25lIGluIHRoZSBleGVyY2lzZSBvZiBhbnkgb2YgDQp0aGUgcmlnaHRzIGFu ZCBwb3dlcnMgaGVyZWluIGdyYW50ZWQsIA0KYXMgZnVsbHkgdG8gYWxsIGludGVudHMgYW5k IHB1cnBvc2VzIGFzIHRoZSB1bmRlcnNpZ25lZCBtaWdodCBvciBjb3VsZCBkbyBpZiANCnBl cnNvbmFsbHkgcHJlc2VudCwgd2l0aCBmdWxsIHBvd2VyIG9mIHN1YnN0aXR1dGlvbiBvciBy ZXZvY2F0aW9uLCBoZXJlYnkgDQpyYXRpZnlpbmcgYW5kIGNvbmZpcm1pbmcgYWxsIHRoYXQg c3VjaCBhdHRvcm5leSBpbiBmYWN0LCBvciBzdWNoIGF0dG9ybmV5DQppbiBmYWN0J3Mgc3Vi c3RpdHV0ZSBvciBzdWJzdGl0dXRlcywgc2hhbGwgbGF3ZnVsbHkgZG8gb3IgY2F1c2UgDQp0 byBiZSBkb25lIGJ5IHZpcnR1ZSBvZiB0aGlzIHBvd2VyIG9mIGF0dG9ybmV5IGFuZCB0aGUg cmlnaHRzIGFuZCANCnBvd2VycyBoZXJlaW4gZ3JhbnRlZC4NClRoZSB1bmRlcnNpZ25lZCBh Y2tub3dsZWRnZXMgdGhhdCB0aGUgZm9yZWdvaW5nIGF0dG9ybmV5cyBpbiBmYWN0LCANCmlu IHNlcnZpbmcgaW4gc3VjaCBjYXBhY2l0eSBhdCB0aGUgcmVxdWVzdCBvZiB0aGUgdW5kZXJz aWduZWQsIGFyZSBub3QgYXNzdW1pbmcNCm5vciByZWxpZXZpbmcsIG5vciBpcyB0aGUgQ29t cGFueSBhc3N1bWluZyBub3IgcmVsaWV2aW5nLCBhbnkgb2YgdGhlIA0KdW5kZXJzaWduZWQg cyByZXNwb25zaWJpbGl0aWVzIHRvIGNvbXBseSB3aXRoIFNlY3Rpb24gMTYgb2YgdGhlDQpF eGNoYW5nZSBBY3Qgb3IgUnVsZSAxNDQgb2YgdGhlIFNlY3VyaXRpZXMgQWN0LiANClRoZSB1 bmRlcnNpZ25lZCBhY2tub3dsZWRnZXMgdGhhdCBuZWl0aGVyIHRoZSBDb21wYW55IA0Kbm9y IHRoZSBmb3JlZ29pbmcgYXR0b3JuZXlzIGluIGZhY3QgYXNzdW1lIChpKSBhbnkgbGlhYmls aXR5IGZvciANCnRoZSB1bmRlcnNpZ25lZCBzIHJlc3BvbnNpYmlsaXR5IHRvIGNvbXBseSB3 aXRoIHRoZSByZXF1aXJlbWVudA0Kb2YgdGhlIEV4Y2hhbmdlIEFjdCwgDQooaWkpIGFueSBs aWFiaWxpdHkgb2YgdGhlIHVuZGVyc2lnbmVkIGZvciBhbnkgZmFpbHVyZSB0byBjb21wbHkg d2l0aCBzdWNoIA0KcmVxdWlyZW1lbnRzLCBvciAoaWlpKSBhbnkgb2JsaWdhdGlvbiBvciBs aWFiaWxpdHkgb2YgdGhlIHVuZGVyc2lnbmVkIA0KZm9yIHByb2ZpdCBkaXNnb3JnZW1lbnQg dW5kZXIgU2VjdGlvbiAxNihiKSBvZiB0aGUgRXhjaGFuZ2UgQWN0Lg0KVGhpcyBQb3dlciBv ZiBBdHRvcm5leSBzaGFsbCByZW1haW4gaW4gZnVsbCBmb3JjZSBhbmQgZWZmZWN0IHVudGls IA0KdGhlIHVuZGVyc2lnbmVkIGlzIG5vIGxvbmdlciByZXF1aXJlZCB0byBmaWxlIEZvcm1z IDMsIDQsIGFuZCBvciBGb3JtcyAxNDQNCndpdGggdGhlIFNFQyB3aXRoIHJlc3BlY3QgdG8g dGhlIHVuZGVyc2lnbmVkJ3MgaG9sZGluZ3Mgb2YgYW5kIHRyYW5zYWN0aW9ucw0KIGluIHNl Y3VyaXRpZXMgaXNzdWVkIGJ5IHRoZSBDb21wYW55LCB1bmxlc3MgZWFybGllciByZXZva2Vk IGJ5IHRoZSB1bmRlcnNpZ25lZA0KaW4gYSBzaWduZWQgd3JpdGluZyBkZWxpdmVyZWQgdG8g dGhlIGZvcmVnb2luZyBhdHRvbnJleXMgaW4gZmFjdC4NCklOIFdJVE5FU1MgV0hFUkVPRiwg dGhlIHVuZGVyc2lnbmVkIGhhcyBjYXVzZWQgdGhpcyBQb3dlciBvZiBBdHRvcm5leSANCnRv IGJlIGV4ZWN1dGVkIGFzIG9mIHRoaXMgNHRoIGRheSBvZiBKYW51YXJ5LCAyMDIzLg0KL3Mv IEtpbSBDLiBEcmFwa2luDQpOYW1lOiBLaW0gQy4gRHJhcGtpbg0K

Jounce Therapeutics (NASDAQ:JNCE)
Gráfica de Acción Histórica
De Ene 2025 a Feb 2025 Haga Click aquí para más Gráficas Jounce Therapeutics.
Jounce Therapeutics (NASDAQ:JNCE)
Gráfica de Acción Histórica
De Feb 2024 a Feb 2025 Haga Click aquí para más Gráficas Jounce Therapeutics.